High risk human papillomavirus (HPV) DNA test positive from female genital organs
ICD-10 R87.81 is a billable code used to indicate a diagnosis of high risk human papillomavirus (hpv) dna test positive from female genital organs.
R87.81 is used to indicate a positive result from a high-risk human papillomavirus (HPV) DNA test conducted on samples obtained from female genital organs. HPV is a sexually transmitted infection that can lead to various health issues, including cervical cancer. The presence of high-risk HPV types, particularly HPV 16 and 18, is a significant risk factor for the development of cervical dysplasia and malignancy. Symptoms may not be present in many cases, as HPV infections can be asymptomatic. However, abnormal findings may include cervical dysplasia detected through Pap smears or visual examinations. The diagnosis is typically confirmed through molecular testing that identifies high-risk HPV DNA. Accurate coding is essential for appropriate patient management and treatment planning, as well as for tracking epidemiological trends in HPV-related diseases.
Documentation should include the reason for testing, results of the HPV test, and any follow-up actions taken.
Routine screening for cervical cancer in women aged 30 and older, follow-up after abnormal Pap results.
Ensure that the patient's history includes any previous HPV infections or treatments.
Acute care documentation should detail the patient's presenting symptoms, test results, and any immediate interventions.
Patients presenting with abnormal vaginal bleeding or pelvic pain who undergo HPV testing.
Consider the urgency of the situation and document any immediate referrals to gynecology.
Used when a patient has a positive Pap smear and requires HPV testing.
Document the reason for the test, results, and any follow-up actions.
Ensure that the test is performed in accordance with guidelines for cervical cancer screening.
A positive high-risk HPV test indicates the presence of HPV types that are associated with an increased risk of cervical cancer. It is important to follow up with appropriate screening and management.
